Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Bernardo F Spiazzi

Showing results (1-10 of 17) with videos related to

Pageof 2
Sort By:
Current Hypertension Reports|January 21, 2026
Addressing Hypertension Treatment Disparities Via Renal DenervationBernardo F Spiazzi, Carolina P Zingano, Luke J Laffin
Journal of Cardiac Failure|July 4, 2026
Time to benefit of incretin-based therapies in adiposity-related heart failure with mildly reduced or preserved ejection fraction: a systematic review and meta-analysisBernardo F Spiazzi, Carolina P Zingano, Amanda R Vest
European Journal of Preventive Cardiology|June 5, 2026
Advancing Hypertension Treatment in Obstructive Sleep ApneaBernardo F Spiazzi, Carolina P Zingano, Luke J Laffin
The Canadian Journal of Cardiology|May 2, 2026
Venous thromboembolism risk among different statins: a retrospective cohort studyBernardo F Spiazzi, Carolina P Zingano, Akiva Rosenzveig, et al.
Nutrients|August 14, 2025
Ultra-Processed Food Intake as an Effect Modifier in the Association Between Depression and Diabetes in Brazil: A Cross-Sectional StudyYunxiang Sun, Poliana E Correia, Paula P Teixeira, et al.
JAMA Cardiology|May 27, 2026
Bempedoic Acid and Venous Thromboembolism Risk Among Statin-Intolerant Patients: A Post Hoc Analysis of the CLEAR Outcomes Randomized Clinical TrialBernardo F Spiazzi, Danielle Brennan, Carolina P Zingano, et al.
Clinical Journal of the American Society of Nephrology : CJASN|September 19, 2024
SGLT2 inhibitors and kidney outcomes across the spectrum of kidney disease: a systematic review and meta-analysisBernardo F Spiazzi, Giovana F Piccoli, Laura F Wayerbacher, et al.
Clinical Journal of the American Society of Nephrology : CJASN|January 10, 2025
Sodium-Glucose Cotransporter 2 Inhibitors and Kidney Outcomes across the Spectrum of Kidney Disease: A Systematic Review and Meta-AnalysisBernardo F Spiazzi, Giovana F Piccoli, Laura F Wayerbacher, et al.
Diabetes Research and Clinical Practice|November 20, 2024
SGLT2 inhibitors, cardiovascular outcomes, and mortality across the spectrum of kidney disease: A systematic review and meta-analysisBernardo F Spiazzi, Giovana F Piccoli, Laura F Wayerbacher, et al.
The Journal of Clinical Endocrinology and Metabolism|March 4, 2023
Cancer Outcomes Among Prediabetes and Type 2 Diabetes Populations With Dietary and Physical Activity-based Lifestyle InterventionsMinghui Zhang, Kelly Pozzer Zucatti, Paula Portal Teixeira, et al.
Pageof 2

Showing results (1-10 of 17) with videos related to

Sort By:
Pageof 2
Current Hypertension Reports|January 21, 2026
Addressing Hypertension Treatment Disparities Via Renal DenervationBernardo F Spiazzi, Carolina P Zingano, Luke J Laffin
Journal of Cardiac Failure|July 4, 2026
Time to benefit of incretin-based therapies in adiposity-related heart failure with mildly reduced or preserved ejection fraction: a systematic review and meta-analysisBernardo F Spiazzi, Carolina P Zingano, Amanda R Vest
European Journal of Preventive Cardiology|June 5, 2026
Advancing Hypertension Treatment in Obstructive Sleep ApneaBernardo F Spiazzi, Carolina P Zingano, Luke J Laffin
The Canadian Journal of Cardiology|May 2, 2026
Venous thromboembolism risk among different statins: a retrospective cohort studyBernardo F Spiazzi, Carolina P Zingano, Akiva Rosenzveig, et al.
Nutrients|August 14, 2025
Ultra-Processed Food Intake as an Effect Modifier in the Association Between Depression and Diabetes in Brazil: A Cross-Sectional StudyYunxiang Sun, Poliana E Correia, Paula P Teixeira, et al.
JAMA Cardiology|May 27, 2026
Bempedoic Acid and Venous Thromboembolism Risk Among Statin-Intolerant Patients: A Post Hoc Analysis of the CLEAR Outcomes Randomized Clinical TrialBernardo F Spiazzi, Danielle Brennan, Carolina P Zingano, et al.
Clinical Journal of the American Society of Nephrology : CJASN|September 19, 2024
SGLT2 inhibitors and kidney outcomes across the spectrum of kidney disease: a systematic review and meta-analysisBernardo F Spiazzi, Giovana F Piccoli, Laura F Wayerbacher, et al.
Clinical Journal of the American Society of Nephrology : CJASN|January 10, 2025
Sodium-Glucose Cotransporter 2 Inhibitors and Kidney Outcomes across the Spectrum of Kidney Disease: A Systematic Review and Meta-AnalysisBernardo F Spiazzi, Giovana F Piccoli, Laura F Wayerbacher, et al.
Diabetes Research and Clinical Practice|November 20, 2024
SGLT2 inhibitors, cardiovascular outcomes, and mortality across the spectrum of kidney disease: A systematic review and meta-analysisBernardo F Spiazzi, Giovana F Piccoli, Laura F Wayerbacher, et al.
The Journal of Clinical Endocrinology and Metabolism|March 4, 2023
Cancer Outcomes Among Prediabetes and Type 2 Diabetes Populations With Dietary and Physical Activity-based Lifestyle InterventionsMinghui Zhang, Kelly Pozzer Zucatti, Paula Portal Teixeira, et al.
Pageof 2